Thursday’s Midday Stock Update: Ocwen Financial (OCN), RXi Pharmaceuticals Corp (RXII), Titan Pharmaceuticals (TTNP), Rockwell Med (RMTI), Fuelcell Energy (FCEL)

By Carrie Williams

So far Thursday, April 20, NASDAQ is up 1.36% and the S&P is up 1.03%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Ocwen Financial (NYSE:OCN), RXi Pharmaceuticals Corp (NASDAQ:RXII), Titan Pharmaceuticals (NASDAQ:TTNP), Rockwell Med (NASDAQ:RMTI) and Fuelcell Energy (NASDAQ:FCEL).

Ocwen Financial is down -26.56% in midday trading to $4.01. Shares opened today at $5.46. The company has a 52-week low of $1.29 and a 52-week high of $6.15. On the Street’s front, the average 12-month analyst price target for the stock is $5, marking a -8.42% potential downside from current levels. In a report issued on April 10, Keefe analyst Bose George reiterated a Hold rating on OCN, with a price target of $5, which represents a potential downside of 8% from where the stock is currently trading. In the last 30 days, insiders purchased $862.3K worth of OCN shares. Over the last 3 months, the insider sentiment on Ocwen Financial has been negative based on 31 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

RXi Pharmaceuticals Corp is down -7.3% in midday trading to $0.68. Shares opened today at $0.73. The company has a 52-week low of $0.60 and a 52-week high of $3.27. Over the last 3 months, the insider sentiment on RXi Pharmaceuticals Corp has been positive based on 11 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

Titan Pharmaceuticals is up 7.27% in midday trading to $2.95. Shares opened today at $2.75. The company has a 52-week low of $2.70 and a 52-week high of $8.74. Over the last 3 months, the insider sentiment on Titan Pharmaceuticals has been positive based on 3 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

Rockwell Med is up 7% in midday trading to $8.41. Shares opened today at $7.86. The company has a 52-week low of $3.55 and a 52-week high of $10.58. Over the last 3 months, the insider sentiment on Rockwell Med has been neutral based on 17 corporate insider transactions. This sentiment is higher than the average sector sentiment of insiders.

Fuelcell Energy is down -6.25% in midday trading to $1.50. Shares opened today at $1.60. The company has a 52-week low of $1.25 and a 52-week high of $8.88. In the last 30 days, insiders have sold $52.55K worth of FCEL shares. Over the last 3 months, the insider sentiment on Fuelcell Energy has been neutral based on 12 corporate insider transactions. This sentiment is higher than the average sector sentiment of insiders.